| Accession Number: | 0001209191-23-048533 |
| Date: | 2023-09-05 |
| Issuer: | SHOCKWAVE MEDICAL, INC. (SWAV) |
| Original Submission Date: |
PHUNG TRINH
C/O SHOCKWAVE MEDICAL, INC.
5403 BETSY ROSS DRIVE
SANTA CLARA, CA 95054
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2023-09-05 | F | 24 | d | $219.56 | 26,027 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|---|
| f1 | all reported securities were sold at a price of $219.56. |
| f2 | the reported total includes an aggregate 65 shares the reporting person has acquired since her form 4 report filed on august 31, 2023 in exempt transactions through automatic payroll deduction and purchase features of the issuers employee stock purchase plan, which is a qualified tax-conditioned plan pursuant to section 423 of the internal revenue code. |
